Evaluating predictive markers for viral rebound and safety assessment in blood and lumbar fluid during HIV-1 treatment interruption
Marie‐Angélique De Scheerder(Ghent University Hospital), Linos Vandekerckhove(Ghent University Hospital), Filip Van Wanzeele(Ghent University Hospital), Nele De Langhe(Ghent University Hospital), Sofie Rutsaert, Jolanda Pelgrom(Ghent University Hospital), Philippe Lemey(KU Leuven), Magnus Gisslén(Sahlgrenska University Hospital), Bram Vrancken(Rega Institute for Medical Research), Clarissa Van Hecke(HOGENT University of Applied Sciences and Arts), Henrik Zetterberg(Queen Mary University of London), Dietmar Fuchs, Bea Van Der Gucht(Ghent University Hospital), Ytse Noppe(Ghent University Hospital), Sarah Palmer(The University of Sydney), Wim Trypsteen(Ghent University Hospital)
Cited by 17
Related Papers
Bayesian Phylogeography Finds Its Roots
|PLoS Computational Biology|2009|1.9k
Defeating Alzheimer's disease and other dementias: a priority for European science and society
|The Lancet Neurology|2016|1.7k
Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma.
|The Journal of Experimental Medicine|1984|1.1k
SpreaD3: Interactive Visualization of Spatiotemporal History and Trait Evolutionary Processes
|Molecular Biology and Evolution|2016|640